Minaris (WuXi Advanced Therapies)

Philadelphia, PA / Yokohama, Japan
CAR-T Cell Therapy
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
60.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Minaris (WuXi Advanced Therapies)

Signal Score
60.5/100 (as of 2026-04-29)
Quality Compliance
Assessment pending
Headquarters
Philadelphia, PA / Yokohama, Japan
Modalities
CAR-T, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Minaris (WuXi Advanced Therapies)

BIOSECURE Act risk.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 58.0
BIOSECURE Act exposure risk
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
BIOSECURE Act exposure risk
Capacity 63.0
3 manufacturing sites
Sites: Philadelphia, PA, Yokohama, Japan, Shanghai, China
Source: SEC EDGAR, press monitoring, company profiles
3 manufacturing sites
3 manufacturing sites

Frequently Asked Questions About Minaris (WuXi Advanced Therapies)

What is Minaris (WuXi Advanced Therapies)'s CDMO Signal Score?
Minaris (WuXi Advanced Therapies) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Minaris (WuXi Advanced Therapies) for a manufacturing program?
Use the free AI matchmaker to compare Minaris (WuXi Advanced Therapies) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.5
CAR-T, Cell Therapy
Hitachi Global Life Solutions (CGT)
Yokohama, Japan
Signal Score: 63.0
Cell Therapy, CAR-T
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.8
CAR-T, Cell Therapy
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.8
CAR-T, Cell Therapy